P Efthimiou

Summary

Affiliation: New Jersey
Country: USA

Publications

  1. ncbi Diagnosis and management of adult onset Still's disease
    P Efthimiou
    Department of Medicine, New Jersey Medical School, UMDNJ, Newark, NJ 07101, USA
    Ann Rheum Dis 65:564-72. 2006
  2. ncbi Possible role for tumour necrosis factor inhibitors in the treatment of resistant dermatomyositis and polymyositis: a retrospective study of eight patients
    P Efthimiou
    Division of Allergy, Immunology and Rheumatology, New Jersey Medical School, University of Medicine and Dentistry of New Jersey, USA
    Ann Rheum Dis 65:1233-6. 2006
  3. ncbi Pathogenesis and management of adult-onset Still's disease
    Petros Efthimiou
    New Jersey Medical School, UMDNJ, Newark, NJ, USA
    Semin Arthritis Rheum 36:144-52. 2006
  4. ncbi Tumor necrosis factor-alpha in inflammatory myopathies: pathophysiology and therapeutic implications
    Petros Efthimiou
    Division of Allergy, Immunology, and Rheumatology, Department of Medicine, New Jersey Medical School, University of Medicine and Dentistry of New Jersey, Newark, NJ, USA
    Semin Arthritis Rheum 36:168-72. 2006
  5. ncbi Adult-onset Still's disease: can recent advances in our understanding of its pathogenesis lead to targeted therapy?
    Petros Efthimiou
    Division of Allergy, Immunology, and Rheumatology, New Jersey Medical School, and Rheumatology Clinic, University Hospital, New Jersey Medical School, University of Medicine and Dentistry of New Jersey, Newark, NJ 07103, USA
    Nat Clin Pract Rheumatol 3:328-35. 2007
  6. ncbi Adult-onset Still's disease: pathogenesis, clinical manifestations and therapeutic advances
    Apostolos Kontzias
    Department of Medicine, Lincoln Medical and Mental Health Center, New York, New York 10451, USA
    Drugs 68:319-37. 2008
  7. ncbi Isolated severe vasculitic neuropathy revealing sarcoidosis
    Nizar Souayah
    Department of Neurosciences, New Jersey Medical School, University of Medicine and Dentistry of New Jersey, Newark, NJ, USA
    Lancet Neurol 7:756-60. 2008
  8. ncbi Role of biological agents in immune-mediated inflammatory diseases
    Petros Efthimiou
    Hospital for Special Surgery, Weill Medical College of Cornell University, New York, New York 10021, USA
    South Med J 98:192-204. 2005
  9. ncbi T cell activation causes diarrhea by increasing intestinal permeability and inhibiting epithelial Na+/K+-ATPase
    Mark W Musch
    The Martin Boyer Laboratories, Department of Medicine, University of Chicago, Chicago, Illinois, USA
    J Clin Invest 110:1739-47. 2002

Collaborators

  • N Souayah
  • Leonard Bielory
  • Apostolos Kontzias
  • Mark W Musch
  • Zheng Zhang
  • Lara R Gawenis
  • Daniel Mamah
  • Terrence A Barrett
  • Ziad Alnadjim
  • Eugene B Chang
  • William Ellsworth
  • Lane L Clarke
  • Navdha Mittal
  • Steve D Hurst
  • David Shalowitz

Detail Information

Publications9

  1. ncbi Diagnosis and management of adult onset Still's disease
    P Efthimiou
    Department of Medicine, New Jersey Medical School, UMDNJ, Newark, NJ 07101, USA
    Ann Rheum Dis 65:564-72. 2006
    ..Adult onset Still's disease (AOSD) is a rare systemic inflammatory disorder of unknown aetiology that is responsible for a significant proportion of cases of fever of unknown origin and can also have serious musculoskeletal sequelae...
  2. ncbi Possible role for tumour necrosis factor inhibitors in the treatment of resistant dermatomyositis and polymyositis: a retrospective study of eight patients
    P Efthimiou
    Division of Allergy, Immunology and Rheumatology, New Jersey Medical School, University of Medicine and Dentistry of New Jersey, USA
    Ann Rheum Dis 65:1233-6. 2006
    ..To understand the use of tumour necrosis factor (TNF)alpha inhibitors in refractory dermatomyositis and polymyositis in an academic centre...
  3. ncbi Pathogenesis and management of adult-onset Still's disease
    Petros Efthimiou
    New Jersey Medical School, UMDNJ, Newark, NJ, USA
    Semin Arthritis Rheum 36:144-52. 2006
    ..To review recent literature regarding the pathogenesis and treatment of adult-onset Still's disease (AOSD)...
  4. ncbi Tumor necrosis factor-alpha in inflammatory myopathies: pathophysiology and therapeutic implications
    Petros Efthimiou
    Division of Allergy, Immunology, and Rheumatology, Department of Medicine, New Jersey Medical School, University of Medicine and Dentistry of New Jersey, Newark, NJ, USA
    Semin Arthritis Rheum 36:168-72. 2006
    ....
  5. ncbi Adult-onset Still's disease: can recent advances in our understanding of its pathogenesis lead to targeted therapy?
    Petros Efthimiou
    Division of Allergy, Immunology, and Rheumatology, New Jersey Medical School, and Rheumatology Clinic, University Hospital, New Jersey Medical School, University of Medicine and Dentistry of New Jersey, Newark, NJ 07103, USA
    Nat Clin Pract Rheumatol 3:328-35. 2007
    ..Recent advances in basic immunology have enhanced our ability to hinder the pathogenic mechanisms associated with adult-onset Still's disease and have led to a paradigm shift where targeted treatments have an increasingly important role...
  6. ncbi Adult-onset Still's disease: pathogenesis, clinical manifestations and therapeutic advances
    Apostolos Kontzias
    Department of Medicine, Lincoln Medical and Mental Health Center, New York, New York 10451, USA
    Drugs 68:319-37. 2008
    ..Further progress has been hampered by the rarity and heterogeneity of the disease, which has not permitted the execution of randomized controlled studies...
  7. ncbi Isolated severe vasculitic neuropathy revealing sarcoidosis
    Nizar Souayah
    Department of Neurosciences, New Jersey Medical School, University of Medicine and Dentistry of New Jersey, Newark, NJ, USA
    Lancet Neurol 7:756-60. 2008
  8. ncbi Role of biological agents in immune-mediated inflammatory diseases
    Petros Efthimiou
    Hospital for Special Surgery, Weill Medical College of Cornell University, New York, New York 10021, USA
    South Med J 98:192-204. 2005
    ..Their role is currently being defined in other autoimmune disorders such as uveitis, sarcoidosis, interstitial lung disease, vasculitis, inflammatory myopathies, graft-versus-host disease, and Sjögren syndrome...
  9. ncbi T cell activation causes diarrhea by increasing intestinal permeability and inhibiting epithelial Na+/K+-ATPase
    Mark W Musch
    The Martin Boyer Laboratories, Department of Medicine, University of Chicago, Chicago, Illinois, USA
    J Clin Invest 110:1739-47. 2002
    ..T cell activation induces luminal fluid accumulation by increasing mucosal permeability and reducing epithelial Na(+)/K(+)-ATPase activity leading to decreased intestinal Na(+) and water absorption...